Characterization of β-galactosidase in leukocytes and fibroblasts of GM1 gangliosidosis heterozygotes compared to normal subjects

Clinical Biochemistry

Volumn 33, Issue 2, 2000, Pages 125-129

  Sopelsa, Andréia Maria Ida ^a,b   Severini, Márcia Helena Aquino ^b   Da Silva, Cláudia Maria Dornelles ^a,b   Tobo, Patrícia Renovato ^a,b   Giugliani, Roberto ^a,b   Coelho, Janice Carneiro ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

galactosidase; GM1 gangliosidosis; Kinetics; Sphingolipidosis

Indexed keywords

BETA GALACTOSIDASE;

ARTICLE; CELL PH; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; FIBROBLAST; GENETIC COUNSELING; GM1 GANGLIOSIDOSIS; HETEROZYGOTE; HUMAN; HUMAN CELL; LEUKOCYTE; MICHAELIS CONSTANT; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; THERMOSTABILITY;

BETA-GALACTOSIDASE; CELLS, CULTURED; ENZYME STABILITY; FIBROBLASTS; GANGLIOSIDOSIS, GM1; HEAT; HETEROZYGOTE DETECTION; HUMANS; KINETICS; LEUKOCYTES; REFERENCE VALUES; SKIN;

EID: 0033996918     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(00)00049-7     Document Type: Article

References (27)

1. Benson P.F., Fensom A.H. The sphingolipidosis and other lipid storage disorders. Benson P.F., Fensom A.H. Genetic biochemical disorders. 1985;89-94 Oxford University Press, New York.
2. Singer H.S., Schafer I.A. White-cell β-galatosidase activity. N Engl J Med. 282:1970;571-578.
3. Suzuki Y, Sakuraba H, Oshima A. β-galatosidase deficiency (β-galatosidosis): GM1 gangliosidosis and Morquio B disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Eds. The metabolic and molecular basis of inherited disease. Pp. 2785-823, 7th ed. New York: McGraw-Hill, 1995.
4. Okada S., O'Brien J.S. Generalized gangliosidosis β-Galatosidase deficiency . Science. 160:1968;1002-1004.
5. Coelho J.C., Wajner M., Burin M.G., Vargas C.R., Giugliani R. Selective screening of 10,000 high-risk brazilian patients for the detection of inborn errors of metabolism. Eur J Pediatr. 156:1997;650-654.
6. Lyon G., Adams R.D., Kolodny E.H. Neurology of hereditary metabolic diseases of children. 2nd ed. 1996;McGraw-Hill, New York.
7. O'Brien JS. The gangliosidosis In: Stambury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, Eds. The metabolic basis of inherited disease. Pp. 945-67, 5th ed. New York: McGraw-Hill, 1983.
8. O'Brien JS. β-galatosidase deficiency (GM1 gangliosidosis, galactosialidosis and Morquio Syndrome type B); Gangliosidose sialidase deficiency (Mucolipidosis IV). In: Scriver CR, Beaudet AL, Sly WS, Valle D, Eds. The metabolic basis of inherited disease. Pp. 1797-806, 6th ed. New York: McGraw-Hill, 1989.
9. Galjaard H., Reuser A.J.J. Clinical, biochemical and genetic heterogeneity in gangliosidosis. Harkness R.A., Cockburn F. Inborn errors of metabolism The culture cell . 1977;139-141 MTP, St. Leonardgate.
10. Norden A.G.W., O'Brien J.S. Ganglioside GM1 β-galatosidase Studies in human liver and brain . Arch Biochem Biophys. 159:1973;383-386.
11. Raghavan A.S., Gajewski A., Kolodny E.H. GM1 ganglioside β-galatosidase in leukocytes and cultured fibroblasts. Clin Chim Acta. 81:1977;47-51.
12. Suzuki Y., Furukawa T., Hoogeveen A.T., Verheijen F., Galjaard H. Adult type GM1 gangliosidosis A complementation study on somatic cell hybrids . Brain Dev. 1:1979;83-87.
13. Farrel D.F., MacMartin M.P. GM1 gangliosidosis Enzymatic variation in a single family . Ann Neurol. 9:1981;232-236.
14. Kobayashi T., Shinnoh N., Kuroiwa Y. Incorporation and degradation of GM1 ganglioside and asialoGM1 ganglioside in cultured fibroblasts from normal individuals and patients with β-galatosidase deficiency. Biochim Biophys Acta. 875:1986;115-121.
15. Kolodny E.H., Mumford R.A. Human leukocyte acid hidrolases Characterization of eleven lysosomal enzymes and study of reactions conditions for their automated analysis . Clin Chim Acta. 70:1976;247-257.
16. Mutoh T., Naoi M., Sobue I., Kiuchi K., Nagatsu T. A microassay for acid β-galatosidase activity toward asialofetuin. Clin Chim Acta. 152:1985;307-314.
17. Mutoh T., Naoi M., Takahashi A., Hoshino M., Nagai Y., Nagatsu T. Aypical adult GM1 gangliosidosis Biochemical comparision with other forms of primary β-galatosidase deficiency . Neurology. 36:1986;1237-1241.
18. Mutoh T., Sobue I., Naoi M., Matsuoka Y., Kiuchi K., Sigimura K. A family with β-galatosidase deficiency Three adults with atypical clinical patterns . Neurology. 36:1986;54-59.
19. Pinsky L., Powell E., Callahan J. GM1 gangliosidosis types 1 and 2 Enzymatic differences in cultured fibroblasts . Nature. 228:1970;1093-1095.
20. Coelho J.C., Sopelsa A.M.I., Tobo P.R., Severini M.H.A., Silva C.D., Giugliani R. Biochemical studies on leukocyte and fibroblast human β-galactosidase. Clin Biochem. 32:1999;167-170.
21. Severini MHA, Silva CD, Sopelsa AMI, Coelho JC, Giugliani R. High frequency of type 1 GM1 gangliosidosis in southern Brazil. Clin Genet 1999; in press.
22. Skoog W.A., Beck W.S. Studies on the fibrinogen, dextran and phytohemaglutinin methods of isolating leukocytes. Blood. 11:1956;436-454.
23. Suzuki K. Globoid cell leukodystrophy (Krabbe Disease) and GM1-gangliosidosis. Glew R.H., Peters S.P. Practical enzimology of sphingolipidosis. 1977;101-136 Alan R. Liss, New York.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
25. Lineweaver H., Burk D. The determination of enzyme dissociation constants. J Am Chem Soc. 56:1934;658-666.
26. Oran O., Demirsoy S., Oguz A., Caglar M., Karan A., Yilgor E. GM1 gangliosidosis type I (Norman-Landing disease) Report of a case with enzymatic analysis of the family . Turkish J Pediat. 22:1980;59-64.
27. Xu Y.K., Ng W.G. Lysosomal enzyme activities among Chinese Leukocyte α-galactosidase and β-galatosidase . Hum Hered. 38:1988;76-82.